These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11494735)
1. [Evaluation of hearing in children with solid tumors treated by chemotherapy]. Gryczyńska D; Rychwalska M; Pekacka K; Krawczyński M; Bodalski J Otolaryngol Pol; 2001; 55(2):179-83. PubMed ID: 11494735 [TBL] [Abstract][Full Text] [Related]
2. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment. Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400 [TBL] [Abstract][Full Text] [Related]
3. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected. Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725 [TBL] [Abstract][Full Text] [Related]
4. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives. Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780 [TBL] [Abstract][Full Text] [Related]
5. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy. Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939 [TBL] [Abstract][Full Text] [Related]
6. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860 [TBL] [Abstract][Full Text] [Related]
7. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy. Weissenstein A; Deuster D; Knief A; Zehnhoff-Dinnesen AA; Schmidt CM Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469 [TBL] [Abstract][Full Text] [Related]
8. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. Knight KR; Kraemer DF; Winter C; Neuwelt EA J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008 [TBL] [Abstract][Full Text] [Related]
9. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients. Waissbluth S; Del Valle Á; Chuang A; Becker A Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605 [TBL] [Abstract][Full Text] [Related]
10. Changes to spontaneous otoacoustic emissions (SOAEs) due to cisplatin administration. Kuroda T; Chida E; Kashiwamura M; Matsumura M; Fukuda S Int J Audiol; 2008 Nov; 47(11):695-701. PubMed ID: 19031228 [TBL] [Abstract][Full Text] [Related]
12. Recovery from cisplatin-induced ototoxicity: a case report and review. Truong MT; Winzelberg J; Chang KW Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1631-8. PubMed ID: 17706797 [TBL] [Abstract][Full Text] [Related]
13. Profound hearing loss from intravertebral artery cisplatin. Wetmore SJ; Koike KJ; Bloomfield SM Otolaryngol Head Neck Surg; 1997 Feb; 116(2):234-7. PubMed ID: 9051071 [No Abstract] [Full Text] [Related]
14. [Hearing loss caused by high dose carboplatin therapy]. Lautermann J; Adamczyk M; ten Cate WJ; Kloke O Laryngorhinootologie; 1998 Feb; 77(2):82-4. PubMed ID: 9555700 [TBL] [Abstract][Full Text] [Related]
15. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters. Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin ototoxicity in children: implications for primary care providers. Helt-Cameron J; Allen PJ Pediatr Nurs; 2009; 35(2):121-7. PubMed ID: 19472677 [TBL] [Abstract][Full Text] [Related]
17. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia]. Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457 [TBL] [Abstract][Full Text] [Related]
18. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients]. Biró K Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694 [TBL] [Abstract][Full Text] [Related]
19. Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer. Yilmaz S; Oktem F; Karaman E Eur Arch Otorhinolaryngol; 2010 Jul; 267(7):1041-4. PubMed ID: 19946777 [TBL] [Abstract][Full Text] [Related]